A novel scaffold for EGFR inhibition: Introducting N-(3-(3-phenylureido)quinoxalin-6-yl) acrylamide derivatives

dc.contributor.author	Laufer, Stefan
dc.contributor.author	Amaral, Daniel N. do
dc.date.accessioned	2020-06-16T15:02:20Z
dc.date.available	2020-06-16T15:02:20Z
dc.date.issued	2019
dc.identifier.issn	2045-2322
dc.identifier.uri	http://hdl.handle.net/10900/101564
dc.language.iso	en	de_DE
dc.publisher	Nature Publishing Group	de_DE
dc.relation.uri	http://dx.doi.org/10.1038/s41598-018-36846-7	de_DE
dc.subject.ddc	500	de_DE
dc.title	A novel scaffold for EGFR inhibition: Introducting N-(3-(3-phenylureido)quinoxalin-6-yl) acrylamide derivatives	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190926111821_03027
utue.personen.roh	do Amaral, Daniel Nascimento
utue.personen.roh	Lategahn, Jonas
utue.personen.roh	Fokoue, Harold Hilarion
utue.personen.roh	Bastos da Silva, Eduardo Miguez
utue.personen.roh	Sant'Anna, Carlos Mauricio R.
utue.personen.roh	Rauh, Daniel
utue.personen.roh	Barreiro, Eliezer J.
utue.personen.roh	Laufer, Stefan
utue.personen.roh	Lima, Lidia Moreira
dcterms.isPartOf.ZSTitelID	Scientific Reports	de_DE
dcterms.isPartOf.ZS-Issue	Article 14	de_DE
dcterms.isPartOf.ZS-Volume	9	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE
utue.fakultaet	07 Mathematisch-Naturwissenschaftliche Fakultät	de_DE